We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Renal Cell Carcinoma

Journal Scan / Research · September 16, 2021

Targeted Therapies Improved Prognosis and Increased Treatment Utilization Among Patients With Synchronous Metastatic RCC

International Journal of Surgical Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

International Journal of Surgical Oncology
Transition to Targeted Therapies Improved the Prognosis and Increased the Utilization of Medical Treatments Among Patients With Synchronous Metastatic Renal Cell Cancer
Int J Surg Oncol 2021 Aug 01;[EPub Ahead of Print], L Laru, H Ronkainen, MH Vaarala

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading